Product 1 is a combination of cagrilintide, a dual amylin and calcitonin receptor agonist, and semaglutide, a GLP-1 agonist.

Product 2 is a combination of cagrilintide, a dual amylin and calcitonin receptor agonist, and Tirzepatide, a GLP-1 agonist.